Evidence map›Paper›PMID 35013873›Full record

ArticleEsophagus : official journal of the Japan Esophageal Society2022

Biased expression of mutant alleles in cancer-related genes in esophageal squamous cell carcinoma.

Masahiko Takahashi, Kazuyoshi Hosomichi, Hirofumi Nakaoka, Haruhito Sakata, Naoya Uesato, Kentaro Murakami, Masayuki Kano, Takeshi Toyozumi, Yasunori Matsumoto, Tetsuro Isozaki and 4 more

Open access · hybridAbstract read
PubMed Publisher
In one paragraph

Article in Esophagus : official journal of the Japan Esophageal Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Masahiko TakahashiDepartment of Frontier Surgery, Graduated School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba City, Chiba, Japan. masahiko0825@gmail.com.ORCID 0000-0001-9734-2207
Kazuyoshi HosomichiDepartment of Bioinformatics and Genomics, Graduate School of Advanced Preventive Medical Sciences, Kanazawa University, Kanazawa, Japan.
Hirofumi NakaokaHuman Genetics Laboratory, National Institute of Genetics, Mishima, Japan.
Haruhito SakataDepartment of Frontier Surgery, Graduated School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba City, Chiba, Japan.
Naoya UesatoDepartment of Frontier Surgery, Graduated School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba City, Chiba, Japan.
Kentaro MurakamiDepartment of Frontier Surgery, Graduated School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba City, Chiba, Japan.
Masayuki KanoDepartment of Frontier Surgery, Graduated School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba City, Chiba, Japan.
Takeshi ToyozumiDepartment of Frontier Surgery, Graduated School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba City, Chiba, Japan.
Yasunori MatsumotoDepartment of Frontier Surgery, Graduated School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba City, Chiba, Japan.
Tetsuro IsozakiDepartment of Frontier Surgery, Graduated School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba City, Chiba, Japan.
Nobufumi SekinoDepartment of Frontier Surgery, Graduated School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba City, Chiba, Japan.
Ryota OtsukaDepartment of Frontier Surgery, Graduated School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba City, Chiba, Japan.
Itsuro InoueHuman Genetics Laboratory, National Institute of Genetics, Mishima, Japan.
Hisahiro MatsubaraDepartment of Frontier Surgery, Graduated School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba City, Chiba, Japan.
Chiba University · JPNational Institute of Genetics · JPKanazawa University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecent progress of large-scale international studies has provided comprehensive catalogs of somatic mutations in cancers. Additionally, it has become evident that allelic imbalance in the abundance of somatic mutations between DNA and RNA were pervasive in various types of cancer. However, the allelic imbalance of the abundance of somatic mutations in esophageal squamous cell carcinoma (ESCC) has not been fully analyzed.

methodsWe performed exome sequencing for 25 Japanese patients with ESCC to detect a comprehensive catalog of somatic mutations in ESCC. Additionally, we performed mRNA sequencing to evaluate the allelic imbalance of the identified somatic mutations at the transcriptional level by comparing the mutant allele frequencies between RNA and DNA.

resultsThe exome sequencing showed that TP53 and ZNF750 were significantly mutated genes. The expression levels of TP53 and ZNF750 were different depending on the mutation status. In almost all the tumors with missense mutations in TP53 and ZNF750, the mutant allele frequencies were higher in the RNA sequencing than those in the exome sequencing, indicating that the mutant alleles were preferentially expressed. By examining the allelic imbalances for all the identified missense mutations, we demonstrated that genes showing preferential expressions of the mutant alleles were involved in the pathways including cell cycle, cell death, and chromatin modification.

conclusionsThe results of this study suggest that the allelic imbalance of the abundance of somatic mutations plays important roles in the initiation and progression of ESCC by modulating cancer-related biological pathways.

Indexed as

Esophageal NeoplasmsEsophageal Squamous Cell CarcinomaTranscription FactorsTumor Suppressor ProteinsAllelesHumansMutationTumor Suppressor Protein p53TP53 protein, humanTranscription FactorsTumor Suppressor Protein p53Tumor Suppressor ProteinsZNF750 protein, humanAllelic imbalanceEsophageal squamous cell carcinomaSequence analysis

Identifiers

PMID35013873
OpenAlexW4205913055

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.